Skip to main content
Erschienen in: Gastric Cancer 5/2022

26.06.2022 | Original Article

Risk factors for the failure of endoscopic resection of gastric submucosal tumors: a long-term retrospective case–control study

verfasst von: Yuzhu Yuan, Lixin Sun, Xiaoying Zhou, Han Chen, Xinmin Si, Weifeng Zhang, Yun Wang, Bixing Ye, Nana Tang, Guoxin Zhang, Xueliang Li, Hongjie Zhang, Chunhua Jiao

Erschienen in: Gastric Cancer | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

Endoscopic resection (ER) is an effective treatment method for gastric submucosal tumors (G-SMTs), but endoscopic resection failure requires emergency surgery. The purpose of this study was to assess potential risk factors for endoscopic resection failure.

Methods

A total of 1041 patients with G-SMT undergoing endoscopic resection were enrolled. Twenty-five patients in whom endoscopic resection failed, requiring a transition to surgery midway through the operation, were included in the failed group, and 1016 patients who received successful endoscopic resection were included in the successful endoscopic resection group. Baseline and lesion characteristics were recorded, and the differences in tumor characteristics and risk factors for resection failure of G-SMT were analyzed. Sensitivity analysis was performed to detect the stability of the indicator.

Results

Of the 1041cases included, there were 25 cases (2.4%) of failed endoscopic resection. Binary logistic analysis showed that the independent risk factors included tumors originating from deep muscularis propria(OR = 14.42, 95% CI 4.4746.52), size > 3 cm (OR = 7.75, 95% CI 2.6422.70), exophytic growth pattern (OR = 4.98, 95% CI 1.6215.29), endoscopist with less experience (OR = 5.99, 95% CI 1.0712.19), and irregular borders (OR = 4.13, 95% CI 1.4012.19). The stable risk factors were tumors size, tumor origin and growth pattern according to sensitivity analysis.

Conclusions

Tumors originating from the deep muscularis propria, tumor size > 3 cm, endoscopists with less experience, an exophytic growth pattern, and irregular boundaries were found to be independent risk factors for endoscopic resection failure. To reduce the risk of endoscopic resection failure, physicians should carefully evaluate G-SMT characteristics preoperative.
Literatur
1.
Zurück zum Zitat Hedenbro JL, Ekelund M, Wetterberg P. Endoscopic diagnosis of submucosal gastric lesions. The results after routine endoscopy. Surg Endosc. 1991;5(1):20–3.PubMedCrossRef Hedenbro JL, Ekelund M, Wetterberg P. Endoscopic diagnosis of submucosal gastric lesions. The results after routine endoscopy. Surg Endosc. 1991;5(1):20–3.PubMedCrossRef
2.
Zurück zum Zitat Iorio N, Sawaya RA, Friedenberg FK. Review article: the biology, diagnosis and management of gastrointestinal stromal tumours. Aliment Pharmacol Ther. 2014;39(12):1376–86.PubMedCrossRef Iorio N, Sawaya RA, Friedenberg FK. Review article: the biology, diagnosis and management of gastrointestinal stromal tumours. Aliment Pharmacol Ther. 2014;39(12):1376–86.PubMedCrossRef
3.
4.
Zurück zum Zitat Lee HL. Advances in the management of upper gastrointestinal subepithelial tumor: pathologic diagnosis using endoscopy without endoscopic ultrasound-guided biopsy. Clin Endosc. 2016;49(3):216–9.PubMedPubMedCentralCrossRef Lee HL. Advances in the management of upper gastrointestinal subepithelial tumor: pathologic diagnosis using endoscopy without endoscopic ultrasound-guided biopsy. Clin Endosc. 2016;49(3):216–9.PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Gu M, Ghafari S, Nguyen PT, Lin F. Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol. 2001;25(6):343–50.PubMedCrossRef Gu M, Ghafari S, Nguyen PT, Lin F. Cytologic diagnosis of gastrointestinal stromal tumors of the stomach by endoscopic ultrasound-guided fine-needle aspiration biopsy: cytomorphologic and immunohistochemical study of 12 cases. Diagn Cytopathol. 2001;25(6):343–50.PubMedCrossRef
6.
Zurück zum Zitat Nishida T, Kawai N, Yamaguchi S, Nishida Y. Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors. Dig Endosc. 2013;25(5):479–89.PubMedCrossRef Nishida T, Kawai N, Yamaguchi S, Nishida Y. Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors. Dig Endosc. 2013;25(5):479–89.PubMedCrossRef
7.
Zurück zum Zitat Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010;8 Suppl 2(2):S1-41.PubMedCrossRef Demetri GD, von Mehren M, Antonescu CR, DeMatteo RP, Ganjoo KN, Maki RG, et al. NCCN Task Force report: update on the management of patients with gastrointestinal stromal tumors. J Natl Compr Canc Netw. 2010;8 Suppl 2(2):S1-41.PubMedCrossRef
8.
Zurück zum Zitat Cai MY, Martin Carreras-Presas F, Zhou PH. Endoscopic full-thickness resection for gastrointestinal submucosal tumors. Dig Endosc. 2018;30(Suppl 1):17–24.PubMedCrossRef Cai MY, Martin Carreras-Presas F, Zhou PH. Endoscopic full-thickness resection for gastrointestinal submucosal tumors. Dig Endosc. 2018;30(Suppl 1):17–24.PubMedCrossRef
9.
Zurück zum Zitat Jeon HK, Kim GH, Lee BE, Park DY, Song GA, Kim DH, et al. Long-term outcome of endoscopic submucosal dissection is comparable to that of surgery for early gastric cancer: a propensity-matched analysis. Gastric Cancer. 2018;21(1):133–43.PubMedCrossRef Jeon HK, Kim GH, Lee BE, Park DY, Song GA, Kim DH, et al. Long-term outcome of endoscopic submucosal dissection is comparable to that of surgery for early gastric cancer: a propensity-matched analysis. Gastric Cancer. 2018;21(1):133–43.PubMedCrossRef
10.
Zurück zum Zitat Meng FS, Zhang ZH, Shan GD, Chen YP, Ji F. Endoscopic submucosal dissection for the treatment of large gastric submucosal tumors originating from the muscularis propria layer: a single center study. Z Gastroenterol. 2015;53(7):655–9.PubMedCrossRef Meng FS, Zhang ZH, Shan GD, Chen YP, Ji F. Endoscopic submucosal dissection for the treatment of large gastric submucosal tumors originating from the muscularis propria layer: a single center study. Z Gastroenterol. 2015;53(7):655–9.PubMedCrossRef
11.
Zurück zum Zitat Abe N, Takeuchi H, Ohki A, Hashimoto Y, Mori T, Sugiyama M. Comparison between endoscopic and laparoscopic removal of gastric submucosal tumor. Dig Endosc. 2018;30(Suppl 1):7–16.PubMedCrossRef Abe N, Takeuchi H, Ohki A, Hashimoto Y, Mori T, Sugiyama M. Comparison between endoscopic and laparoscopic removal of gastric submucosal tumor. Dig Endosc. 2018;30(Suppl 1):7–16.PubMedCrossRef
12.
Zurück zum Zitat Meng FS, Zhang ZH, Hong YY, Li DJ, Lin JQ, Chen X, et al. Comparison of endoscopic submucosal dissection and surgery for the treatment of gastric submucosal tumors originating from the muscularis propria layer: a single-center study (with video). Surg Endosc. 2016;30(11):5099–107.PubMedCrossRef Meng FS, Zhang ZH, Hong YY, Li DJ, Lin JQ, Chen X, et al. Comparison of endoscopic submucosal dissection and surgery for the treatment of gastric submucosal tumors originating from the muscularis propria layer: a single-center study (with video). Surg Endosc. 2016;30(11):5099–107.PubMedCrossRef
13.
Zurück zum Zitat Yu C, Liao G, Fan C, Yu J, Nie X, Yang S, et al. Long-term outcomes of endoscopic resection of gastric GISTs. Surg Endosc. 2017;31(11):4799–804.PubMedCrossRef Yu C, Liao G, Fan C, Yu J, Nie X, Yang S, et al. Long-term outcomes of endoscopic resection of gastric GISTs. Surg Endosc. 2017;31(11):4799–804.PubMedCrossRef
14.
Zurück zum Zitat Tashiro T, Hasegawa T, Omatsu M, Sekine S, Shimoda T, Katai H. Gastrointestinal stromal tumour of the stomach showing lymph node metastases. Histopathology. 2005;47(4):438–9.PubMedCrossRef Tashiro T, Hasegawa T, Omatsu M, Sekine S, Shimoda T, Katai H. Gastrointestinal stromal tumour of the stomach showing lymph node metastases. Histopathology. 2005;47(4):438–9.PubMedCrossRef
15.
Zurück zum Zitat Aparicio T, Boige V, Sabourin JC, Crenn P, Ducreux M, Le Cesne A, et al. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. Eur J Surg Oncol. 2004;30(10):1098–103.PubMedCrossRef Aparicio T, Boige V, Sabourin JC, Crenn P, Ducreux M, Le Cesne A, et al. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours. Eur J Surg Oncol. 2004;30(10):1098–103.PubMedCrossRef
16.
Zurück zum Zitat Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H, et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer. 1996;77(4):602–6.PubMedCrossRef Yamao T, Shirao K, Ono H, Kondo H, Saito D, Yamaguchi H, et al. Risk factors for lymph node metastasis from intramucosal gastric carcinoma. Cancer. 1996;77(4):602–6.PubMedCrossRef
17.
Zurück zum Zitat Toyonaga T, Man-i M, East JE, Nishino E, Ono W, Hirooka T, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;27(3):1000–8.PubMedCrossRef Toyonaga T, Man-i M, East JE, Nishino E, Ono W, Hirooka T, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;27(3):1000–8.PubMedCrossRef
18.
Zurück zum Zitat Goto O, Uraoka T, Horii J, Yahagi N. Expanding indications for ESD: submucosal disease (SMT/carcinoid tumors). Gastrointest Endosc Clin N Am. 2014;24(2):169–81.PubMedCrossRef Goto O, Uraoka T, Horii J, Yahagi N. Expanding indications for ESD: submucosal disease (SMT/carcinoid tumors). Gastrointest Endosc Clin N Am. 2014;24(2):169–81.PubMedCrossRef
19.
Zurück zum Zitat Nagami Y, Ominami M, Sakai T, Maruyama H, Fukunaga S, Otani K, et al. Predictive factors for difficult endoscopic submucosal dissection for esophageal neoplasia including failure of en bloc resection or perforation. Surg Endosc. 2021;35(7):3361–9.PubMedCrossRef Nagami Y, Ominami M, Sakai T, Maruyama H, Fukunaga S, Otani K, et al. Predictive factors for difficult endoscopic submucosal dissection for esophageal neoplasia including failure of en bloc resection or perforation. Surg Endosc. 2021;35(7):3361–9.PubMedCrossRef
20.
Zurück zum Zitat Zhang Y, Wang Z, Jin T, Li KQ, Hao K, Zhang W, et al. Hyperechoic demarcation line between a tumor and the muscularis propria layer as a marker for deciding the endoscopic treatment of gastric submucosal tumor. J Zhejiang Univ Sci B. 2017;18(8):707–16.PubMedPubMedCentralCrossRef Zhang Y, Wang Z, Jin T, Li KQ, Hao K, Zhang W, et al. Hyperechoic demarcation line between a tumor and the muscularis propria layer as a marker for deciding the endoscopic treatment of gastric submucosal tumor. J Zhejiang Univ Sci B. 2017;18(8):707–16.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Aida K, Yoshikawa H, Mochizuki C, Mori A, Muto S, Fukuda T, et al. Clinicopathological features of gastric cancer detected by endoscopy as part of annual health checkup. J Gastroenterol Hepatol. 2008;23(4):632–7.PubMedCrossRef Aida K, Yoshikawa H, Mochizuki C, Mori A, Muto S, Fukuda T, et al. Clinicopathological features of gastric cancer detected by endoscopy as part of annual health checkup. J Gastroenterol Hepatol. 2008;23(4):632–7.PubMedCrossRef
22.
Zurück zum Zitat Kim J, Kim SG, Chung H, Lim JH, Choi JM, Park JY, et al. Clinical efficacy of endoscopic ultrasonography for decision of treatment strategy of gastric cancer. Surg Endosc. 2018;32(9):3789–97.PubMedCrossRef Kim J, Kim SG, Chung H, Lim JH, Choi JM, Park JY, et al. Clinical efficacy of endoscopic ultrasonography for decision of treatment strategy of gastric cancer. Surg Endosc. 2018;32(9):3789–97.PubMedCrossRef
23.
Zurück zum Zitat Kumano S, Murakami T, Kim T, Hori M, Iannaccone R, Nakata S, et al. T staging of gastric cancer: role of multi-detector row CT. Radiology. 2005;237(3):961–6.PubMedCrossRef Kumano S, Murakami T, Kim T, Hori M, Iannaccone R, Nakata S, et al. T staging of gastric cancer: role of multi-detector row CT. Radiology. 2005;237(3):961–6.PubMedCrossRef
24.
Zurück zum Zitat An W, Sun PB, Gao J, Jiang F, Liu F, Chen J, et al. Endoscopic submucosal dissection for gastric gastrointestinal stromal tumors: a retrospective cohort study. Surg Endosc. 2017;31(11):4522–31.PubMedCrossRef An W, Sun PB, Gao J, Jiang F, Liu F, Chen J, et al. Endoscopic submucosal dissection for gastric gastrointestinal stromal tumors: a retrospective cohort study. Surg Endosc. 2017;31(11):4522–31.PubMedCrossRef
25.
Zurück zum Zitat Fukuda H, Uedo N, Shichijo S. Traction-assisted endoscopic full-thickness resection for extraluminal type gastrointestinal stromal tumor. Endosc Int Open. 2021;9(8):E1243–5.PubMedPubMedCentralCrossRef Fukuda H, Uedo N, Shichijo S. Traction-assisted endoscopic full-thickness resection for extraluminal type gastrointestinal stromal tumor. Endosc Int Open. 2021;9(8):E1243–5.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Hu J, Liu W, Chen Z, Lin D, Su M, Lan P. A novel snare traction-assisted method during endoscopic resection for upper gastrointestinal submucosal tumors. J Laparoendosc Adv Surg Tech A. 2021;31(4):416–22.PubMedCrossRef Hu J, Liu W, Chen Z, Lin D, Su M, Lan P. A novel snare traction-assisted method during endoscopic resection for upper gastrointestinal submucosal tumors. J Laparoendosc Adv Surg Tech A. 2021;31(4):416–22.PubMedCrossRef
27.
Zurück zum Zitat Shi Q, Chen T, Zhong YS, Zhou PH, Ren Z, Xu MD, et al. Complete closure of large gastric defects after endoscopic full-thickness resection, using endoloop and metallic clip interrupted suture. Endoscopy. 2013;45(5):329–34.PubMedCrossRef Shi Q, Chen T, Zhong YS, Zhou PH, Ren Z, Xu MD, et al. Complete closure of large gastric defects after endoscopic full-thickness resection, using endoloop and metallic clip interrupted suture. Endoscopy. 2013;45(5):329–34.PubMedCrossRef
28.
Zurück zum Zitat Matsuda T, Fujii T, Emura F, Kozu T, Saito Y, Ikematsu H, et al. Complete closure of a large defect after EMR of a lateral spreading colorectal tumor when using a two-channel colonoscope. Gastrointest Endosc. 2004;60(5):836–8.PubMedCrossRef Matsuda T, Fujii T, Emura F, Kozu T, Saito Y, Ikematsu H, et al. Complete closure of a large defect after EMR of a lateral spreading colorectal tumor when using a two-channel colonoscope. Gastrointest Endosc. 2004;60(5):836–8.PubMedCrossRef
29.
Zurück zum Zitat Chen Q, Yu M, Lei Y, Zhong C, Liu Z, Zhou X, et al. Efficacy and safety of endoscopic submucosal dissection for large gastric stromal tumors. Clin Res Hepatol Gastroenterol. 2020;44(1):90–100.PubMedCrossRef Chen Q, Yu M, Lei Y, Zhong C, Liu Z, Zhou X, et al. Efficacy and safety of endoscopic submucosal dissection for large gastric stromal tumors. Clin Res Hepatol Gastroenterol. 2020;44(1):90–100.PubMedCrossRef
30.
Zurück zum Zitat Xu MD, Cai MY, Zhou PH, Qin XY, Zhong YS, Chen WF, et al. Submucosal tunneling endoscopic resection: a new technique for treating upper GI submucosal tumors originating from the muscularis propria layer (with videos). Gastrointest Endosc. 2012;75(1):195–9.PubMedCrossRef Xu MD, Cai MY, Zhou PH, Qin XY, Zhong YS, Chen WF, et al. Submucosal tunneling endoscopic resection: a new technique for treating upper GI submucosal tumors originating from the muscularis propria layer (with videos). Gastrointest Endosc. 2012;75(1):195–9.PubMedCrossRef
31.
Zurück zum Zitat Choi IJ, Kim CG, Chang HJ, Kim SG, Kook MC, Bae JM. The learning curve for EMR with circumferential mucosal incision in treating intramucosal gastric neoplasm. Gastrointest Endosc. 2005;62(6):860–5.PubMedCrossRef Choi IJ, Kim CG, Chang HJ, Kim SG, Kook MC, Bae JM. The learning curve for EMR with circumferential mucosal incision in treating intramucosal gastric neoplasm. Gastrointest Endosc. 2005;62(6):860–5.PubMedCrossRef
32.
Zurück zum Zitat Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 2016;19(1):3–14.PubMedCrossRef Nishida T, Blay JY, Hirota S, Kitagawa Y, Kang YK. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines. Gastric Cancer. 2016;19(1):3–14.PubMedCrossRef
33.
Zurück zum Zitat Chun SY, Kim KO, Park DS, Lee IJ, Park JW, Moon SH, et al. Endoscopic submucosal dissection as a treatment for gastric subepithelial tumors that originate from the muscularis propria layer: a preliminary analysis of appropriate indications. Surg Endosc. 2013;27(9):3271–9.PubMedPubMedCentralCrossRef Chun SY, Kim KO, Park DS, Lee IJ, Park JW, Moon SH, et al. Endoscopic submucosal dissection as a treatment for gastric subepithelial tumors that originate from the muscularis propria layer: a preliminary analysis of appropriate indications. Surg Endosc. 2013;27(9):3271–9.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Liu BR, Song JT, Qu B, Wen JF, Yin JB, Liu W. Endoscopic muscularis dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria. Surg Endosc. 2012;26(11):3141–8.PubMedCrossRef Liu BR, Song JT, Qu B, Wen JF, Yin JB, Liu W. Endoscopic muscularis dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria. Surg Endosc. 2012;26(11):3141–8.PubMedCrossRef
35.
Zurück zum Zitat Białek A, Wiechowska-Kozłowska A, Pertkiewicz J, Karpińska K, Marlicz W, Milkiewicz P, et al. Endoscopic submucosal dissection for the treatment of neoplastic lesions in the gastrointestinal tract. World J Gastroenterol. 2013;19(12):1953–61.PubMedPubMedCentralCrossRef Białek A, Wiechowska-Kozłowska A, Pertkiewicz J, Karpińska K, Marlicz W, Milkiewicz P, et al. Endoscopic submucosal dissection for the treatment of neoplastic lesions in the gastrointestinal tract. World J Gastroenterol. 2013;19(12):1953–61.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Min YW, Park HN, Min BH, Choi D, Kim KM, Kim S. Preoperative predictive factors for gastrointestinal stromal tumors: analysis of 375 surgically resected gastric subepithelial tumors. J Gastrointest Surg. 2015;19(4):631–8.PubMedCrossRef Min YW, Park HN, Min BH, Choi D, Kim KM, Kim S. Preoperative predictive factors for gastrointestinal stromal tumors: analysis of 375 surgically resected gastric subepithelial tumors. J Gastrointest Surg. 2015;19(4):631–8.PubMedCrossRef
37.
Zurück zum Zitat Kang HC, Menias CO, Gaballah AH, Shroff S, Taggart MW, Garg N, et al. Beyond the GIST: mesenchymal tumors of the stomach. Radiographics. 2013;33(6):1673–90.PubMedPubMedCentralCrossRef Kang HC, Menias CO, Gaballah AH, Shroff S, Taggart MW, Garg N, et al. Beyond the GIST: mesenchymal tumors of the stomach. Radiographics. 2013;33(6):1673–90.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Li QL, Yao LQ, Zhou PH, Xu MD, Chen SY, Zhong YS, et al. Submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a large study of endoscopic submucosal dissection (with video). Gastrointest Endosc. 2012;75(6):1153–8.PubMedCrossRef Li QL, Yao LQ, Zhou PH, Xu MD, Chen SY, Zhong YS, et al. Submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a large study of endoscopic submucosal dissection (with video). Gastrointest Endosc. 2012;75(6):1153–8.PubMedCrossRef
39.
Zurück zum Zitat Ohta T, Ishihara R, Uedo N, Takeuchi Y, Nagai K, Matsui F, et al. Factors predicting perforation during endoscopic submucosal dissection for gastric cancer. Gastrointest Endosc. 2012;75(6):1159–65.PubMedCrossRef Ohta T, Ishihara R, Uedo N, Takeuchi Y, Nagai K, Matsui F, et al. Factors predicting perforation during endoscopic submucosal dissection for gastric cancer. Gastrointest Endosc. 2012;75(6):1159–65.PubMedCrossRef
40.
Zurück zum Zitat Kim MN, Kang SJ, Kim SG, Im JP, Kim JS, Jung HC, et al. Prediction of risk of malignancy of gastrointestinal stromal tumors by endoscopic ultrasonography. Gut Liver. 2013;7(6):642–7.PubMedPubMedCentralCrossRef Kim MN, Kang SJ, Kim SG, Im JP, Kim JS, Jung HC, et al. Prediction of risk of malignancy of gastrointestinal stromal tumors by endoscopic ultrasonography. Gut Liver. 2013;7(6):642–7.PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Chak A, Canto MI, Rösch T, Dittler HJ, Hawes RH, Tio TL, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc. 1997;45(6):468–73.PubMedCrossRef Chak A, Canto MI, Rösch T, Dittler HJ, Hawes RH, Tio TL, et al. Endosonographic differentiation of benign and malignant stromal cell tumors. Gastrointest Endosc. 1997;45(6):468–73.PubMedCrossRef
42.
Zurück zum Zitat Hu ML, Wu KL, Changchien CS, Chuah SK, Chiu YC. Endosonographic surveillance of 1–3 cm gastric submucosal tumors originating from muscularis propria. World J Gastroenterol. 2017;23(12):2194–200.PubMedPubMedCentralCrossRef Hu ML, Wu KL, Changchien CS, Chuah SK, Chiu YC. Endosonographic surveillance of 1–3 cm gastric submucosal tumors originating from muscularis propria. World J Gastroenterol. 2017;23(12):2194–200.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Lachter J, Bishara N, Rahimi E, Shiller M, Cohen H, Reshef R. EUS clarifies the natural history and ideal management of GISTs. Hepatogastroenterology. 2008;55(86–87):1653–6.PubMed Lachter J, Bishara N, Rahimi E, Shiller M, Cohen H, Reshef R. EUS clarifies the natural history and ideal management of GISTs. Hepatogastroenterology. 2008;55(86–87):1653–6.PubMed
44.
Zurück zum Zitat Hoteya S, Yamashita S, Kikuchi D, Nakamura M, Fujimoto A, Matsui A, et al. Endoscopic submucosal dissection for submucosal invasive gastric cancer and curability criteria. Dig Endosc. 2011;23(1):30–6.PubMedCrossRef Hoteya S, Yamashita S, Kikuchi D, Nakamura M, Fujimoto A, Matsui A, et al. Endoscopic submucosal dissection for submucosal invasive gastric cancer and curability criteria. Dig Endosc. 2011;23(1):30–6.PubMedCrossRef
45.
Zurück zum Zitat Shimoda R, Iwakiri R, Sakata H, Ogata S, Kikkawa A, Ootani H, et al. Evaluation of endoscopic hemostasis with metallic hemoclips for bleeding gastric ulcer: comparison with endoscopic injection of absolute ethanol in a prospective, randomized study. Am J Gastroenterol. 2003;98(10):2198–202.PubMedCrossRef Shimoda R, Iwakiri R, Sakata H, Ogata S, Kikkawa A, Ootani H, et al. Evaluation of endoscopic hemostasis with metallic hemoclips for bleeding gastric ulcer: comparison with endoscopic injection of absolute ethanol in a prospective, randomized study. Am J Gastroenterol. 2003;98(10):2198–202.PubMedCrossRef
Metadaten
Titel
Risk factors for the failure of endoscopic resection of gastric submucosal tumors: a long-term retrospective case–control study
verfasst von
Yuzhu Yuan
Lixin Sun
Xiaoying Zhou
Han Chen
Xinmin Si
Weifeng Zhang
Yun Wang
Bixing Ye
Nana Tang
Guoxin Zhang
Xueliang Li
Hongjie Zhang
Chunhua Jiao
Publikationsdatum
26.06.2022
Verlag
Springer Nature Singapore
Erschienen in
Gastric Cancer / Ausgabe 5/2022
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-022-01306-9

Weitere Artikel der Ausgabe 5/2022

Gastric Cancer 5/2022 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.